Related Experiment Video
Updated: Jul 24, 2026
06:52
Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
Adverse drug reactions in elderly patients
P A Routledge1, M S O'Mahony, K W Woodhouse
1Department of Pharmacology, Therapeutics and Toxicology, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, Wales, UK. proutledge@compuserve.com
British Journal of Clinical Pharmacology
|January 30, 2004
Summary
Elderly patients are at high risk for adverse drug reactions (ADRs), especially those taking multiple medications. Understanding drug interactions and improving communication are key to preventing these potentially avoidable events.
Area of Science:
- Geriatric Medicine
- Clinical Pharmacology
- Patient Safety
Background:
- Increasing age correlates with a higher rate of adverse drug reactions (ADRs).
- Over 80% of hospital-related ADRs are dose-dependent (Type A) and potentially preventable.
- Frail elderly patients, often on multiple medications, are particularly vulnerable to ADRs and drug interactions.
Purpose of the Study:
- To highlight the risks of ADRs in the elderly population.
- To emphasize the importance of recognizing and preventing drug interactions and ADRs.
- To discuss strategies for mitigating ADRs in aging patients receiving polypharmacy.
Main Methods:
- Review of existing studies on age and ADRs.
- Analysis of the nature and predictability of Type A ADRs.
- Discussion of preventative strategies including communication, education, and technology.
Main Results:
- Polypharmacy in the elderly increases the risk of synergistic drug toxicity.
- Inadequate therapy due to fear of ADRs can lead to hospital admissions.
- Age alone should not preclude adequate dosing of necessary medications.
Conclusions:
- Effective communication and therapeutic partnerships are crucial for ADR prevention.
- Education in evidence-based therapeutics and use of decision support systems are vital.
- Healthcare professionals must report suspected adverse drug events to ensure patient safety.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...